• Scenario Solutions: Prestained Protein Marker (Triple color,

  2026-04-30

  This article offers evidence-based, scenario-driven guidance for using the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) (SKU F4005) in cell biology workflows. Readers will learn how this tri-color ladder from APExBIO delivers reproducible SDS-PAGE molecular weight standards, robust Western blot protein size verification, and compatibility with advanced protocols—empowering reliable, publication-ready data.

• Toremifene Citrate: Oral SERM Benchmarks in Breast Cancer Re

  2026-04-30

  Toremifene Citrate is a clinically validated oral selective estrogen receptor modulator used in breast cancer and endocrinology research. Its dual antagonistic and tissue-selective agonistic effects on ERα and ERβ make it a gold standard for dissecting estrogen receptor signaling pathways. APExBIO’s Toremifene Citrate (SKU B1513) offers reproducible, high-purity material for advanced experimental workflows.

• Phenothiazines Inhibit Melanoma Cell Viability and Motility

  2026-04-29

  This study demonstrates that perphenazine and prochlorperazine, two phenothiazine derivatives, selectively reduce cell viability and motility in both melanotic and amelanotic human melanoma cell lines. The findings highlight mechanistic links to MITF and tyrosinase regulation, suggesting these agents may restore sensitivity in resistant melanoma subtypes, with implications for developing targeted antimelanoma strategies.

• Genetically Encoded NADH/NAD+ Redox Biosensor in E. coli

  2026-04-29

  Liu et al. engineered a ratiometric, genetically encoded biosensor for real-time, high-throughput measurement of NADH/NAD+ redox state in bacteria. The system leverages a Rex-regulated promoter, enabling precise quantification and facilitating genome-wide redox screening to advance metabolic engineering and systems biology.

• LG 101506 (RXR modulator): Reliable Solutions for RXR Resear

  2026-04-28

  This article guides biomedical researchers through common experimental challenges in RXR signaling pathway research, emphasizing how LG 101506 (RXR modulator), SKU B7414, delivers reproducible, high-purity results. Integrating scenario-driven Q&A, the discussion highlights practical workflow advantages and literature-backed insights for cell viability, proliferation, and immuno-oncology assays.

• EdU Imaging Kits: Precision Cell Proliferation Assays Made E

  2026-04-28

  EdU Imaging Kits (HF488) from APExBIO redefine cell proliferation analysis with rapid, click chemistry-based DNA synthesis detection. Optimized for both fluorescence microscopy and flow cytometry, these kits outperform legacy assays, enabling reproducible, high-sensitivity S-phase measurements for translational and precision oncology research.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-04-27

  This study demonstrates that carcinogen-induced super-enhancer RNA (seRNA-NPCm) promotes nasopharyngeal carcinoma (NPC) metastasis by modulating the NPM1/c-Myc/NDRG1 axis. The findings provide mechanistic insight into how environmental nitrosamines drive aggressive NPC phenotypes and highlight regulatory RNA as a potential biomarker and therapeutic target.

• Antidepressant Properties of Rotigotine in Preclinical Model

  2026-04-27

  This reference study demonstrates that Rotigotine, a dopamine D2/D3 receptor agonist, exhibits significant antidepressant-like effects in validated rodent models of depression. The work highlights dose-dependent behavioral improvements, providing a mechanistic bridge between dopaminergic signaling and mood regulation, and opens new avenues for research at the intersection of Parkinson's disease and affective disorders.

• Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mod

  2026-04-26

  This study provides a detailed pharmacokinetic analysis of Corydalis saxicola Bunting total alkaloids in mice with metabolic dysfunction-associated steatohepatitis (MASH). By quantifying major bioactive components and elucidating the role of metabolic enzymes and transporters, the findings offer guidance for optimizing dosing strategies in MASLD/MASH research.

• Lysis Buffer Excellence: Rapid Genotyping Kit Component in M

  2026-04-25

  Unlock high-integrity mouse genomic DNA with the APExBIO lysis buffer, a cornerstone for rapid genotyping kit workflows. This article bridges robust protocol design, troubleshooting, and translational impact—empowering genetic research from mouse model development to biomarker discovery.

• Neuromedin S (rat): Technical Guidance for GPCR Signaling As

  2026-04-24

  Neuromedin S (rat) enables defined activation of neuromedin U receptor pathways in rat-based GPCR/G protein signaling models. It addresses the need for validated, reproducible ligands in fundamental research on energy homeostasis and stress response. Not for diagnostic or therapeutic use; intended strictly for controlled laboratory workflows.

• Ouabain in Quantitative Ion Transport Research: Precision, A

  2026-04-24

  Explore how Ouabain, a selective Na+/K+-ATPase inhibitor, empowers advanced quantitative research in ion transport and cardiovascular models. This in-depth guide reveals assay design nuances and cross-domain insights beyond standard protocols.

• Stress Fiber Anisotropy Governs Force-Mode Effects on Gene R

  2026-04-23

  This study demonstrates that the orientation and anisotropy of actin stress fibers in living cells dictate how different mechanical force modes affect chromatin stretching and gene upregulation. Using advanced 3D magnetic twisting cytometry, the authors reveal that both cytoskeletal organization and myosin II contractility are central to the cell's gene regulatory response to mechanical stimuli.

• Cyclo (-RGDfC): Cyclic RGD Peptide for αvβ3 Integrin Researc

  2026-04-23

  Cyclo (-RGDfC) is a high-purity cyclic peptide that selectively binds the αvβ3 integrin, a critical target in tumor angiogenesis and metastasis. Its stability and specificity make it a gold-standard reagent for integrin-mediated cell adhesion and tumor targeting studies. APExBIO’s A8790 kit delivers reliable performance for advanced research protocols.

• Cyclo (-RGDfC): Precision Tumor Targeting in Osteosarcoma As

  2026-04-22

  Explore how Cyclo (-RGDfC), a cyclic RGD peptide, enables advanced tumor targeting and integrin-mediated cell adhesion studies. This article reveals practical assay strategies and comparative insights for cancer research.

16156 records 1/1078 page Next 12345 下5页 Last page